• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anticancer 20(R)-dammarane-3β,12β,20,25-tetrol-loaded polymeric micelles: Preparation, quantification and pharmacokinetics.负载抗癌20(R)-达玛烷-3β,12β,20,25-四醇的聚合物胶束:制备、定量及药代动力学
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jun 1;1022:13-20. doi: 10.1016/j.jchromb.2016.03.045. Epub 2016 Apr 1.
2
Determination of 25-OH-PPD in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.高效液相色谱-质谱法测定大鼠血浆中25-羟基-泼尼松龙及其在大鼠药代动力学研究中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 15;858(1-2):65-70. doi: 10.1016/j.jchromb.2007.08.021. Epub 2007 Aug 23.
3
Determination of Dammar-20(22)E,24-Diene-3β,6α,12β-Triol in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.采用液相色谱-串联质谱法测定大鼠血浆中达玛-20(22)E,24-二烯-3β,6α,12β-三醇及其在药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jan 15;1189:123039. doi: 10.1016/j.jchromb.2021.123039. Epub 2021 Nov 23.
4
Gender-related differences in pharmacokinetics, tissue distribution, and excretion of 20(R)-25-methoxyl-dammarane-3β,12β,20-triol and its metabolite in rats and anti-ovarian cancer evaluation.大鼠体内 20(R)-25-甲氧基达玛烷-3β,12β,20-三醇及其代谢物的药代动力学、组织分布和排泄的性别差异及抗卵巢癌作用评价。
J Pharm Biomed Anal. 2018 Sep 5;158:327-338. doi: 10.1016/j.jpba.2018.06.010. Epub 2018 Jun 7.
5
Determination of 25-OCH3-PPD and the related substances by UPLC-MS/MS and their cytotoxic activity.采用超高效液相色谱-串联质谱法测定25-OCH3-PPD及其有关物质,并研究其细胞毒性活性。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jun 1;1022:274-280. doi: 10.1016/j.jchromb.2016.04.031. Epub 2016 Apr 19.
6
Simultaneous determination by LC-MS/MS of 25-methoxydammarane-3β,12β,20-triol epimers and active metabolites in rat plasma after intravenous administration.液相色谱-串联质谱法同时测定大鼠静脉给药后血浆中25-甲氧基达玛烷-3β,12β,20-三醇差向异构体及活性代谢产物
Xenobiotica. 2013 Oct;43(10):868-74. doi: 10.3109/00498254.2013.789149. Epub 2013 Apr 30.
7
Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation.用于提高20(S)-25-甲氧基-达玛烷-3β,12β,20-三醇口服生物利用度的自微乳化药物递送系统:制备与评价
Int J Nanomedicine. 2014 Feb 12;9:913-20. doi: 10.2147/IJN.S56894. eCollection 2014.
8
Stereoselective pharmacokinetics of 25-methoxyl-dammarane-3β,12β,20-triol and its active demethyl-metabolite epimers in rats after oral and intravenous administration.25-甲氧基-达玛烷-3β,12β,20-三醇及其活性去甲基代谢物差向异构体在大鼠口服和静脉给药后的立体选择性药代动力学
Fitoterapia. 2017 Jan;116:139-145. doi: 10.1016/j.fitote.2016.12.002. Epub 2016 Dec 8.
9
[Determination of nine ginsenosides in health foods by solid extraction phase-ultra performance liquid chromatography-tandem mass spectrometry].固相萃取-超高效液相色谱-串联质谱法测定保健食品中的九种人参皂苷
Se Pu. 2021 May;39(5):526-533. doi: 10.3724/SP.J.1123.2020.04028.
10
Simultaneous determination of gypenoside LVI, gypenoside XLVI, 2α-OH-protopanaxadiol and their two metabolites in rat plasma by LC-MS/MS and its application to pharmacokinetic studies.采用液相色谱-串联质谱法同时测定大鼠血浆中绞股蓝皂苷LVI、绞股蓝皂苷XLVI、2α-羟基原人参二醇及其两种代谢产物,并将其应用于药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Nov 15;1005:9-16. doi: 10.1016/j.jchromb.2015.09.028. Epub 2015 Sep 25.

本文引用的文献

1
Simultaneous determinations of 17 marker compounds in Xiao-Chai-Hu-Tang by LC-MS/MS: Application to its pharmacokinetic studies in mice.采用液相色谱-串联质谱法同时测定小柴胡汤中17种标志物化合物:及其在小鼠体内的药代动力学研究应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 15;1003:12-21. doi: 10.1016/j.jchromb.2015.09.004. Epub 2015 Sep 11.
2
Preparation Procedure and Pharmacokinetic Study of Water-in-Oil Nanoemulsion of Panax Notoginseng Saponins for Improving the Oral Bioavailability.三七总皂苷油包水纳米乳提高口服生物利用度的制备工艺及药代动力学研究
Curr Drug Deliv. 2016;13(4):600-10. doi: 10.2174/1567201812666150608095517.
3
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action.抗癌人参皂苷25 - OCH3 - PPD的口服纳米递送,MDM2癌基因的天然抑制剂:纳米颗粒制备、表征、体外和体内抗前列腺癌活性及作用机制
Oncotarget. 2015 Aug 28;6(25):21379-94. doi: 10.18632/oncotarget.4091.
4
Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry.采用超高效液相色谱-串联质谱法对芫花活性成分芫花碱的药代动力学特征及代谢产物进行鉴定
J Pharm Biomed Anal. 2015 Aug 10;112:60-9. doi: 10.1016/j.jpba.2015.04.023. Epub 2015 Apr 25.
5
Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation.新型虎杖苷纳米脂质体递送系统:制备、表征及体内评价
Drug Des Devel Ther. 2015 Mar 30;9:1805-13. doi: 10.2147/DDDT.S77615. eCollection 2015.
6
The use of natural products in colorectal cancer drug discovery.天然产物在结直肠癌药物研发中的应用。
Expert Opin Drug Discov. 2015 Apr;10(4):411-26. doi: 10.1517/17460441.2015.1018174. Epub 2015 Feb 27.
7
Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action.三七总皂苷治疗急性脑出血的疗效与安全性、荟萃分析及潜在作用机制的简要综述
Front Neurol. 2015 Jan 7;5:274. doi: 10.3389/fneur.2014.00274. eCollection 2014.
8
Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview.人参作为癌症治疗剂的最新进展:功能和机制概述。
Nat Prod Rep. 2015 Feb;32(2):256-72. doi: 10.1039/c4np00080c.
9
Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.三种人参皂苷衍生物在肺癌中的抗肿瘤活性与Wnt/β-连环蛋白信号通路抑制有关。
Eur J Pharmacol. 2014 Nov 5;742:145-52. doi: 10.1016/j.ejphar.2014.08.032. Epub 2014 Sep 6.
10
Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.三七总皂苷对心脑血管疾病的保护作用:实验研究的综合概述。
Evid Based Complement Alternat Med. 2014;2014:204840. doi: 10.1155/2014/204840. Epub 2014 Jul 24.

负载抗癌20(R)-达玛烷-3β,12β,20,25-四醇的聚合物胶束:制备、定量及药代动力学

Anticancer 20(R)-dammarane-3β,12β,20,25-tetrol-loaded polymeric micelles: Preparation, quantification and pharmacokinetics.

作者信息

Yu Junxian, Li Zhe, Wang Wei, Zhang Yang, Li Dandan, Liu Yi, Shen Su, Zhang Ruiwen

机构信息

Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA; Cancer Biology Center, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jun 1;1022:13-20. doi: 10.1016/j.jchromb.2016.03.045. Epub 2016 Apr 1.

DOI:10.1016/j.jchromb.2016.03.045
PMID:27070116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5224911/
Abstract

Polymeric micelles are effective drug-loading sites and often used to formulate poorly water-soluble agents. In the present study, the amphiphilic copolymer methoxy-capped poly(ethyleneglycol)-block-poly(Ɛ-caprolactone) (mPEG-b-PCL) was successfully developed for the delivery of 20(R)-dammarane-3β,12β,20,25-tetrol (25-OH-PPD), a natural anticancer product from Panax notoginseng. The 25-OH-PPD-loaded micelles were characterized by morphological observation and thermodynamic stability testing. The concentrations of 25-OH-PPD was determined by HPLC-MS/MS. The optimum MRM transition of 25-OH-PPD was selected at m/z 479.4.0→461.4. The chromatographic separation was achieved on a SB-C18 column (1.8μm, 2.1×50mm) with an optimized gradient mobile phase system. The extraction recoveries of plasma and various tissue homogenates were within the range of 81.1%-110.4% and the matrix effects ranged from 81.9% to 106.7%. The intra- and inter- day precision values (RSD%) were less than 12.0%, with accuracies ranging from 85.2% to 114.2%. In addition, 25-OH-PPD was found to be stable in different biological matrix after three freeze-thaw cycles, at room temperature and at -70°C for 4 weeks. The pharmacokinetics of 25-OH-PPD-loaded micelles was evaluated in rats. The micelles appeared as transparent liquid, stable and uniform spheres with an average particle size of 35.4±4.2nm. The maximum concentration of 25-OH-PPD in micelles was much lower than in free drug preparation. However, the drug in the micelles was released steadily, with a t1/2 of 9.1±4.0h, significantly longer than in free drug (3.3±1.4h). However, the drug concentrations in tissues after the micelle administration were lower than the levels after administration of the free drugs. In summary, the micelles were characterized by long circulation and sustained release, with an ability to avoid uptake by the reticuloendothelial system, providing a promising approach to deliver intravenous 25-OH-PPD for therapy.

摘要

聚合物胶束是有效的药物负载部位,常用于配制水溶性差的药物。在本研究中,成功开发了两亲性共聚物甲氧基封端的聚乙二醇 - 聚己内酯(mPEG-b-PCL),用于递送三七中的天然抗癌产物20(R)-达玛烷-3β,12β,20,25-四醇(25-OH-PPD)。通过形态观察和热力学稳定性测试对负载25-OH-PPD的胶束进行了表征。采用HPLC-MS/MS测定25-OH-PPD的浓度。选择25-OH-PPD的最佳多反应监测(MRM)跃迁为m/z 479.4→461.4。在SB-C18柱(1.8μm,2.1×50mm)上,采用优化的梯度流动相系统实现了色谱分离。血浆和各种组织匀浆的提取回收率在81.1% - 110.4%范围内,基质效应在81.9%至106.7%之间。日内和日间精密度值(RSD%)小于12.0%,准确度在85.2%至114.2%之间。此外,发现25-OH-PPD在经历三次冻融循环后,在室温及-70°C下保存4周时,在不同生物基质中均稳定。在大鼠中评估了负载25-OH-PPD胶束的药代动力学。胶束呈现为透明液体,是稳定且均匀的球体,平均粒径为35.4±4.2nm。胶束中25-OH-PPD的最大浓度远低于游离药物制剂中的浓度。然而,胶束中的药物释放稳定,t1/2为9.1±4.0h,明显长于游离药物(3.3±1.4h)。然而,胶束给药后组织中的药物浓度低于游离药物给药后的水平。总之,该胶束具有长循环和缓释的特点,能够避免被网状内皮系统摄取,为静脉注射25-OH-PPD进行治疗提供了一种有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/d5e82d75c6be/nihms-776911-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/374e8b7d7336/nihms-776911-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/b0e20d4b166f/nihms-776911-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/868009005b50/nihms-776911-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/33b03f5aabfb/nihms-776911-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/d5e82d75c6be/nihms-776911-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/374e8b7d7336/nihms-776911-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/b0e20d4b166f/nihms-776911-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/868009005b50/nihms-776911-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/33b03f5aabfb/nihms-776911-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcd9/5224911/d5e82d75c6be/nihms-776911-f0005.jpg